Culture Wars Reach Labeling For COVID-19 Treatments

 
• By Derrick Gingery

Senators ask US FDA to change statements in COVID-19 monoclonal antibody fact sheets that factors like race or ethnicity may place a patient high-risk of serious illness, saying they promote racist decisions.

picking person from a crowd
CDC data shows that some minority groups have higher rates of hospitalization and death from COVID-19 compared to Whites. • Source: Alamy

More from Diversity & Inclusion

More from Clinical Trials